Research article · 2017
Conference abstract
Dissolution testing for generic drugs: An FDA perspective
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
I n vitro dissolution testing is an important tool used for development and approval of generic dosage forms. Th e objective of this presentation is to summarize how dissolution testing is used for the approval of safe and eff ective generic drug products in the United States (US). Dissolution testing is routinely used for stability and quality control purposes for both oral and non-oral dosage forms. Th e dissolution method should be developed using an appropriate validated method depending on the dosage form. Th ere are several ways in which dissolution testing plays a pivotal role in regulatory decision-making. It may be used to waive in vivo bioequivalence (BE) study requirements, as BE documentation for Scale Up and Post Approval Changes (SUPAC), and to predict the potential for a modifi ed-release (MR) drug product to dose-dump if co-administered with alcoholic beverages. Th us, in vitro dissolution testing plays a major role in FDA?s eff orts to reduce the regulatory burden and unnecessary human studies in generic drug development without sacrifi cing the quality of the drug products
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 12 Jun 2026
FDA Bioequivalence Evaluation and Its Role in Generic Drug Approval
Conference abstract · 12 Nov 2013
Quality by design: Generic versus brand drug development, delays in review of drug applications at FDA, regulatory problems and solutions
Conference abstract
Updates on US-FDA?s bioequivalence approaches for generic drug products
Conference abstract
Employing design of experiment approach in the optimization of a generic drug product formula in reaction with the similarity index of dissolution profile for the drug product innovator
More from this journal
The newest in Journal of Bioequivalence & Bioavailability.
Article · 5 Oct 2026
Long COVID in pediatric and young adult patients: a review of evaluation for microvascular changes, endothelial dysfunction, and arterial stiffness
Article · 12 Jun 2026
Advances in Bioavailability Through Innovative Drug Delivery Systems and Formulation Technologies
Article · 12 Jun 2026
Bioequivalence Study Design and Methodological Approaches in Generic Drug Evaluation
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Om An”
